Evidence map›Paper›PMID 38932550›Full record

ReviewSheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi2024

[

Xiaoqi Li, Xiao Sun, Hua Lin, Peisen Zhang, Mingxia Jiao, Ni Zhang

Abstract readReviewEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Review in Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaoqi LiCollege of Chemical and Molecular Engineering, Qingdao University of Science and Technology, Qingdao, Shandong 266042, P. R. China.
Xiao SunCollege of Chemical and Molecular Engineering, Qingdao University of Science and Technology, Qingdao, Shandong 266042, P. R. China.
Hua LinWest China Hospital of Sichuan University, Chengdu 610041, P. R. China.
Peisen ZhangCollege of Chemical and Molecular Engineering, Qingdao University of Science and Technology, Qingdao, Shandong 266042, P. R. China.
Mingxia JiaoCollege of Chemical and Molecular Engineering, Qingdao University of Science and Technology, Qingdao, Shandong 266042, P. R. China.
Ni ZhangWest China Hospital of Sichuan University, Chengdu 610041, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Near-infrared fluorescence imaging technology, which possesses superior advantages including real-time and fast imaging, high spatial and temporal resolution, and deep tissue penetration, shows great potential for tumor imaging

Indexed as

CadmiumNeoplasmsOptical ImagingQuantum DotsAnimalsDrug Delivery SystemsHumansInfrared RaysPhotochemotherapySpectroscopy, Near-InfraredCadmiumIn vivo imagingNear-infrared photoluminescenceQuantum dotsTumor therapy

Identifiers

PMID38932550
PMCPMC11208639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.